Assembly Bill 503 seeks to amend the definition of hemp within Wisconsin's Controlled Substances Act. The bill redefines hemp as the plant Cannabis sativa L. and its derivatives, with a total tetrahydrocannabinol (THC) concentration, including tetrahydrocannabinolic acid, of not more than 0.3 percent on a dry weight basis. It also introduces the term "industrial hemp," which encompasses various uses of the plant, such as for stalk, seeds, and edible products. The bill clarifies that hemp does not include certain products, such as viable cannabis seeds exceeding the THC threshold or hemp-derived cannabinoid products that contain synthesized cannabinoids or quantifiable amounts of THC.

Additionally, the bill includes several amendments to existing statutes to align with the new definition of hemp. Notably, it renumbers and amends section 94.55 (1) to reflect the plural "Definitions" and specifies that hemp-derived cannabinoid products do not include FDA-approved prescription drugs. Other amendments involve the removal of the term "delta-9-tetrahydrocannabinol" in favor of "tetrahydrocannabinol" in various sections, ensuring consistency in terminology. Overall, the bill aims to clarify the legal status of hemp and its derivatives while maintaining regulatory oversight.

Statutes affected:
Bill Text: 94.55(2)(b)2m.b, 94.55, 94.55(2)(b)4s, 94.55(3m)(a)2, 94.67(15c), 94.67, 446.01(2)(a), 446.01, 450.03(1)(k), 450.03, 450.07(1m), 450.07, 961.01(14), 961.01, 961.14(4)(t)3, 961.14, 961.32(2m)(b), 961.32, 961.32(3)(a)2